Inner Logic

About Inner Logic

Inner Logic Inc., formerly known as Semaphor Surgical, provides a simulation and AI software infrastructure for the development and testing of procedural medical devices. The company's platform is designed for medical device manufacturers, enabling them to design, test, and validate new technologies like orthopedic implants, heart valves, and surgical robots in a virtual environment before proceeding to physical trials. By simulating performance across thousands of virtual patients and procedures grounded in real-world data, the platform aims to reduce development costs, shorten iteration cycles, and decrease reliance on expensive cadaver and animal studies. The company was founded in 2023 in Baltimore, Maryland, by a team from Johns Hopkins University. The founders are CEO Dr. Tito Porras, who left his neurosurgery residency at Johns Hopkins Hospital to establish the company; CTO Dr. Mathias Unberath, a computer vision and simulation researcher at Johns Hopkins; and Chief Robotics Officer Dr. Axel Krieger, a professor of Mechanical Engineering at Johns Hopkins best known for his work on the Smart Tissue Autonomous Robot (STAR). Their collective expertise, spanning over 400 publications and 40 patents, forms the company's scientific foundation. Inner Logic’s core technology combines physics-based simulation, computer vision, and 3D digital twins, creating an intelligence layer that allows surgical tools and robotic systems to perceive, plan, and act in real-time. This infrastructure is vendor-neutral and designed to integrate with existing clinical and regulatory workflows, providing traceable and documented development cycles to support regulatory submissions. The ultimate goal is to enable the creation of intelligent and autonomous surgical systems, making high-quality care more consistent and accessible. In July 2026, the company announced an $11.5 million seed funding round co-led by General Catalyst and Bison Ventures to expand its simulation platform.